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Abstract
Predicting teenage drug use is key to understanding the etiology of substance
abuse. However, classic predictive modeling procedures are prone to overfitting and fail
to generalize to independent observations. To mitigate these concerns, cross-validated
logistic regression with elastic-net regularization was used to predict cannabis use by age
16 from a large sample of fourteen year olds (N=1,319). High-dimensional data (p =
2,413) including parent and child psychometric data, child structural and functional MRI
data, and genetic data (candidate single-nucleotide polymorphisms, “SNPs”) collected at
age 14 were used to predict the initiation of cannabis use (minimum six occasions) by age
16. Analyses were conducted separately for males and females to uncover sex-specific
predictive profiles. The performance of the predictive models were assessed using the
area under the receiver-operating characteristic curve (“ROC AUC”). Final models
returned high predictive performance (generalization mean ROC AUCmales=.71, mean
ROC AUCfemales=.81) and contained psychometric features common to both sexes. These
common psychometric predictors included greater stressful life events, novelty-seeking
personality traits of both the parent and child, and parental cannabis use. In contrast,
males exhibited distinct functional neurobiological predictors related to a responseinhibition fMRI task, whereas females exhibited distinct neurobiological predictors
related to a social processing fMRI task. Furthermore, the brain predictors exhibited sexspecific effects as the brain predictors of cannabis use for one sex failed to predict
cannabis use for the opposite sex. These sex-specific brain predictors also exhibited drugspecific effects as they failed to predict binge-drinking by age 16 in an independent
sample of youths. When collapsed across sex, a gene-specific analysis suggested that
opioid receptor genetic variation also predicted cannabis use by age 16. Two SNPs on the
gene coding for the primary mu-opioid receptor exhibited genetic risk effects, while one
SNP on the gene coding for the primary delta-opioid receptor exhibited genetic protective
effects. Taken together, these results demonstrate that adolescent cannabis use is reliably
predicted in males and females from shared and unique biobehavioral features. These
analyses also underscore the need for refined predictive modeling procedures as well as
sex-specific inquiries into the etiology of substance abuse. The sex-specific risk-profiles
uncovered from these analyses might inform potential etiological mechanisms
contributing to substance abuse in adolescence as all predictors were measured prior to
the onset of cannabis use.
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Chapter 1: Introduction and Literature Review
Inquiry into the nature of adolescence and drug use can be approached using
animal models and human studies. In this introduction, we will review a sampling of the
adolescent literature pioneered by many scientists who made great efforts in studying
animals and humans during arguably the most fascinating yet challenging period of
development. Here, we will review the biobehavioral characteristics of adolescents who
use drugs, while considering important sex-differences. The empirical work reported in
the second half of this thesis probes a major longitudinal study to uncover sex-specific
predictive profiles of adolescents who initiated cannabis use by age 16. These profiles are
comprised of psychometric, brain, and genetic features, all of which preceded their
cannabis use. Therefore, this review will pay special attention to the relationship between
cannabis use and psychosocial and neurobiological development.

1.1 Adolescent Psychosocial Development
Adolescence is a developmental period of considerable changes during which the
individual navigates the transition between childhood dependence and adulthood
independence. Throughout this period, the adolescent will experiment with novel
behaviors, environments, and reinforcers in order to learn new skills necessary for
independence. Youthful behavioral patterns from childhood that previously sustained the
individual will be phased out and replaced by adult-like behaviors and personality traits
developed during experimentation with independence.
During adolescence, the individual experiences a drive to emigrate from the natal
family environment and begins to incorporate more peers into their social network. In a
1

study on adolescent social interactions, adolescents report communicating with their
peers throughout 33% of their waking hours during a typical week, compared to 8% of
their waking hours communicating with adults (Csikszentmihalyi, Larson, & Prescott,
1977). Hence, increased interactions with peers provide opportunities for the adolescent
to experiment with and learn social skills necessary for adulthood. Furthermore,
motivation to emigrate from the home and associate with peers is evolutionarily
advantageous in order to find genetically dissimilar reproductive partners.

1.2 Risk-taking in Adolescence
When the adolescent spends more time within their social network of peers,
various novel environments and social interactions will arise, some of which involving
the potential for risk. In these settings, adolescents may be more susceptible to engage in
risky behaviors in the presence of peers (Rose et al., 1996). One study identified more
than half of adolescents report ever engaging in driving under the influence of drugs or
alcohol, unsafe sexual activity, criminal activity, and/or substance use (Arnett, 1992), the
latter of which will be surveyed extensively in this thesis. After participating in risktaking behaviors, adolescents may enjoy social reinforcement from their peers (Kaplan,
Johnson, & Bailey, 1987) along with a boost in self-esteem (Shedler & Block, 1990).
Additionally, adolescents report they approach risk in order to satisfy curiosity and
augment the sense of arousal, intensity, and complexity of novel experiences (Lipsett &
Mitnick, 1991). Unfortunately, risk-taking activity can have dire impacts on adolescents
as the majority of mortality during this period is comprised of homicide, suicide, and
accidental death (Irwin Jr, 1989, 1993). While risk-taking appears to be a common
2

feature of adolescence, the ability to moderate the frequency and severity of risky
activities is an important skill that must also be learned during this period.
A propensity for risk-taking behaviors is commonly operationalized in
psychometric questionnaires aimed at measuring the construct of a novelty-seeking
personality (Cloninger, 1999; Woicik et al., 2009). In studies of psychosocial
development, novelty-seeking personality levels typically peak during adolescence
(Maggs, Almeida, & Galambos, 1995; Moffitt, 1993). As such, an elevated noveltyseeking personality is highly predictive of engaging in substance use (Hale et al., 2003;
Mccormick et al., 1998; Sher & Trull, 1994), a topic we will consider extensively in this
thesis. Adolescents also tend to discount delayed rewards in favor of immediate rewards
(Steinberg, 2008) and display an insensitivity to both punishment and the aversive
properties of some drugs (Cauffman et al., 2010; Doremus-Fitzwater, Varlinskaya, &
Spear, 2010; Schramm-Sapyta, Morris, & Kuhn, 2006). Taken together, these behavioral
characteristics make adolescents especially vulnerable to engage in risky behaviors like
substance use.

1.3 Stress in Adolescence
Animal models of stress reactivity consistently report that adolescents exhibit
augmented behavioral signs of stress compared to adult animals when subjected to
physiological (Veenema, 2009; Wagner, 1993) and social stressors (Einon & Morgan,
1977; McGivern et al., 1996; Stone & Quartermain, 1997). Behavioral signs of stress are
supported by elevated hormonal stress levels, with some studies reporting the highest
levels of corticosterone in adolescent female rats compared to adolescent males and adult
3

female rats (Cirulli, Terranova, & Laviola, 1996; Gabriel, Roncancio, & Ruiz, 1992).
Interestingly, surgical and pharmacological ablation of the stress response system has
been shown to attenuate alcohol (Fahlke et al., 1994) and cocaine consumption (Goeders
& Guerin, 1996), thus highlighting a key contribution of these systems in the
development of drug consuming behaviors.
Studies on stress in humans mirror that of the animal studies and suggests the
magnitude of stress perception is greater in adolescent females than adolescent males and
adult females (Hampel & Petermann, 2006). Indeed, numerous studies have identified
frequency of early life stressors (Barrett & Turner, 2006), as well as perceived level of
stress (Baer et al., 1987; Deykin, Levy, & Wells, 1987; Johnson & Pandina, 1993;
Tschann et al., 1994) as strong predictors of substance use in adolescence. In studies of
early life stress, findings indicated that physical and/or sexual abuse during childhood is
more frequent in females than males, but nonetheless strongly predicts substance abuse
later in life for both sexes (Liebschutz et al., 2002). For males, severity of later drug use
was inversely correlated with age at first abuse, such that the younger the age of physical
and/or sexual abuse, the more severe substance abuse problems later in life. This dose
response relationship was not evident in females, as any history of abuse during childhood
strongly predicted substance use problems in adulthood (Liebschutz et al., 2002). In a
related study on the association between post-traumatic stress disorder (PTSD) and later
substance abuse, findings indicated that PTSD from sexual abuse predicted cocaine use in
males, while PTSD from physical abuse predicted cocaine use in females (Hyman et al.,
2005). Taken together, prior life stress might promote the generation of maladaptive
coping strategies like substance use. Despite the association between stress and substance
4

abuse, it is challenging to infer causality for a multifaceted phenotype. Furthermore, while
stress may precede drug use and lead an individual to consume drugs (DeWit, MacDonald,
& Offord, 1999; Tschann et al., 1994; Wills, 1986), drugs and drug-seeking behaviors
may potentiate perceptual and biological reactivity to stress (Cinciripini et al., 1989; Cobb
& Van Thiel, 1982; D’Souza et al., 2004; Heesch et al., 1995).
Despite the relationship between stress and drug use in females, overall rates of drug
use and addiction tend to be higher in men (Kuhn, 2015), possibly due to women being
more sensitive to the stigma associated with use. In terms of treatment, women with
substance abuse problems progress faster towards treatment than men (Hernandez-Avila,
Rounsaville, & Kranzler, 2004). In general, these findings are also applicable to
adolescents. Next, we will focus more specifically on rates of drug use and the features
that correlate with drug use in adolescence

1.4 Substance Use in Adolescence
Alcohol is currently the most commonly used substance in adolescence. In 2015,
nearly half of all 10th graders (ages 14-16) reported any lifetime use, and over a quarter
reported ever being drunk (Johnston et al., 2011). Indeed, numerous studies of alcoholism
have found that an increase in alcohol use during adolescence predicts problematic
drinking (Armario et al., 1987; Barnes & Welte, 1986; Hawkins et al., 1997; Robins &
Przybeck, 1985) as well as the use of other drugs (Yamaguchi & Kandel, 1984) in
adulthood. This relationship might also be reciprocal, as the initiation of illicit drugs
predicts alcohol abuse later in life (Robins & Przybeck, 1985). Problematic drinking in
adolescence is concerning, as teens who abuse alcohol might exhibit behavioral signs of
5

dependence that mirrors adults (Pollock & Martin, 1999), but escalate more rapidly
(Clark, Kirisci, & Tarter, 1998) despite a shorter duration of problematic drinking
behaviors. Furthermore, alcohol dependent teens exhibit similar rates of relapse following
treatment to that of adults (I. Grant et al., 2003). Importantly, the likelihood of becoming
dependent on alcohol decreases by 14% with every year that alcohol initiation is
postponed (B. F. Grant, Stinson, & Harford, 2001). Therefore, the ability to predict atrisk youth to target prevention strategies is of substantial value.
Regardless of sex, adolescents who complete puberty at an earlier age than their
peers are more likely to initiate alcohol, however, early pubertal development is a better
predictor of alcohol dependence in in females (Costello, 2007). In a path analysis
attempting to uncover the mediators of problematic drinking later in life, authors found
that the effect of gender on problematic drinking was mediated by proactive parenting
style, such that greater proactive parenting styles on female offspring reduced the
likelihood of problematic drinking later in life (Hawkins et al., 1997). The role of
parental influence on drug use will be considered again in a later section.
Beyond alcohol use, tobacco use is very common in adolescence, although rates
have declined over time. Nearly 20% of 10th graders report ever smoking cigarettes in
2015, compared to nearly 40% in 2005 (Johnston et al., 2011). Nonetheless, tobacco is
often used in tandem with other drugs. In one study of teens who entered substance abuse
programs, nearly 85% report comorbid nicotine dependence (Stewart & Brown, 1995).
Likewise, alcohol and tobacco use tend to be highly correlated with cannabis use, in
addition to being highly correlated with each other (Moss, Chen, & Yi, 2014).
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1.4.1 Parental Influence
Parents may indirectly contribute to the likelihood of their offspring using
substances. Indeed, the risk of an offspring abusing or becoming dependent on alcohol is
strongly increased when raised by parents with alcohol abuse or dependency problems
(Lieb et al., 2002). Likewise, the risk of becoming a tobacco smoker is nearly doubled
when raised by a parent who smokes (Patton et al., 1998), a finding that has been
replicated and reportedly magnified by maternal smoking (Melchior et al., 2010). Similar
patterns of parent-offspring drug transmission regarding cannabis use have also been
identified (Duncan et al., 1995; Kerr, Tiberio, & Capaldi, 2015). While many factors may
contribute to parent-offspring transmission of drug use, possible mechanisms include
shared neurobiological predispositions, or parental mimicry.
Parenting style has also been correlated with adolescent behaviors. Typically, an
inverse relationship between parental monitoring and drug use is present, such that
decreased parental monitoring may facilitate drug use in adolescence. One study suggest
this relationship is most pronounced when parental monitoring is decreased prior to or in
early adolescence, as low levels of monitoring at age 11 was most strongly correlated
with later drug use (Chilcoat & Anthony, 1996). A similar study corroborated these
findings and specifically identified parental knowledge of their adolescent’s location on
Saturday nights as the strongest predictor of adolescent drug use levels (Ledoux et al.,
2002). Given that adolescence is also marked by an increase in perceived parentoffspring conflict (Palermo, 2014), stressed relationships between parent and adolescent
could have behavioral health implications.
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1.5 Cannabis Use and Adolescence
Longitudinal studies of adolescent development suggest cannabis use is typically
initiated between the ages of 16 to 18 (Chen & Kandel, 1995). In terms of the availability
of the drug, 10th graders in 2015 reported that cannabis was just as easy to obtain as
cigarettes (Johnston et al., 2011). According to a national survey, current rates of
cannabis use among adolescents are high, with a quarter of all 10th graders, and over a
third of all 12th graders in the US reporting trying cannabis at least once (2014). Chronic
use also appears to be growing; in 2008, 5.5% of users aged 12 and older reported near
daily use while in 2013 this rate had risen to 8.1% (2014). These increasing rates of use
are consequential in that about 10% of those who try cannabis will become weekly users
in adulthood (Hall & Pacula, 2003).

1.5.1. Cognition
Cannabis use is frequently described as compromising cognitive abilities, at least
under acute intoxication. Impairments in attention, memory, and processing speeds are
commonly reported in the literature. A meta-analysis of the neurocognitive findings in
adult cannabis users suggests impairments do not persist after prolonged abstinence (I.
Grant et al., 2003). However, the extent to which these problems abate with abstinence
for adolescent users remains unclear.
In studies of cognition in adolescent cannabis users, findings are relatively
inconclusive, with more evidence pointing to cognitive deficits in teens reporting heavy
or earlier onset of use. These cognitive deficits are usually with regard to sustained
attention and working memory (Crane et al., 2015; Harvey et al., 2007). Research by
8

Tapert and colleagues examined cognitive development in relation to cannabis use in a
longitudinal study of teens. Early reports found a decrease in composite attention scores
with cannabis use (Tapert et al., 2002). These findings were corroborated later and
suggest that chronic cannabis use throughout the course of adolescence is associated with
a decrease in complex attention, slow processing speeds, and reduced verbal learning and
sequencing skills (Jacobus & Tapert, 2014; Medina et al., 2007).
In terms of the lasting effects, Schwartz and colleagues report short-term memory
impairments persist at least six-weeks after monitored abstinence (Schwartz et al., 1989).
However, in a prospective study by Fried, Gary, & Watkins, researchers analyzed
cognitive performance in current users, former users, and never-using controls, while
accounting for performance levels prior to drug use. Investigators assessed cognitive
ability across many domains (IQs, memory, processing speed, attention) using an
extensive battery. Findings indicated that current cannabis users performed worse than
the non-users across all domains. However, former users had performance levels similar
to never-users despite initiating use earlier and consuming more of the drug than the
current users. It will be valuable to see if these effects replicate in larger representative
samples as this study contained n=16 former users who also had the highest
socioeconomic status (SES) compared to the two comparison groups (Fried, Watkinson,
& Gray, 2005). Taken together, it is challenging to compare findings across investigators
as the use of different tasks and participant confounders precludes replication or
invalidation.
Lastly, in relation to cognitive ability, Lane and colleagues assessed motivation in
adolescent cannabis users using a reward task that allowed subjects to switch task
9

difficulties for smaller monetary reinforcement. Heavy users switched task difficulties at
an earlier rate than their non-using peers, and earned a greater proportion of their
earnings from the smaller reinforcement level. Interestingly, this proportion of earnings
was correlated with the amount of cannabinoids present in participant urine samples on
the day of testing (Lane et al., 2005). This finding was also displayed in adults tested
under acute intoxication of smoking cannabis compared to placebo (Lane & Cherek,
2002). Thus, cannabis use is associated with impaired motivation and sensitivity to
reward, at least under acute and lingering effects. Authors conclude that cannabis use
might disrupt healthy motivational processes that coordinate favorable behavioral
adaptations (Lane et al., 2005).
As exemplified by Fried, Gary, & Watkins, studies failing to find a correlation
between cannabis use and cognitive impairment in adolescence are evident in the
literature (Tait, Mackinnon, & Christensen, 2011; Takagi et al., 2011; Teichner et al.,
2000). However, they are poorly represented and overshadowed by investigators
publishing in support of the hypothesis that cannabis use compromises cognition.
Nonetheless, functional MRI (fMRI) studies of cannabis use in adolescence, though
sparse, typically do not find between group behavioral task differences but report brain
differences. Therefore, cannabis use in adolescence might better be characterized by
neuroimaging modalities.

1.5.2. Genes
To date, there have been two genome-wide association studies (GWAS) of
cannabis use dependence. In the most recent GWAS study, researchers uncovered three
10

single nucleotide polymorphisms (SNPs) as having an association with cannabis use
dependence (Sherva et al., 2016). One SNP was found on an antisense transcription
region (RP11-206M11.7, rs143244591) whose function is unknown. The other SNPs
were found on a gene coding for a protein that regulates extracellular calcium
concentrations (SLC35G1, rs146091982), and a gene coding for a protein that regulates
neuronal inflammation (CSMD1, rs77378271). Thus highlighting the potential of
identifying predictors of cannabis use from brain and genetic features.
In the earlier GWAS study, none of the SNPs identified passed significance levels
appropriate for GWAS studies (p < 1.0 x 10-8). Nonetheless, researchers reported a small
collection of marginally significant SNPs on intron and non-genic regions on the genome,
for which the authors were unable to provide a mechanistic interpretation for their
contribution to cannabis use (Agrawal et al., 2011). However, the authors offered a
review of candidate-gene analyses and suggest genes coding for neurotransmitter (e.g.,
cannabinoid, opioid, dopamine) receptors, and relevant neurotransmitter enzymes (e.g.,
fatty-acid amide hydrolase, FAAH) might be better suited to uncover genetic associations
with cannabis use (Agrawal & Lynskey, 2009).
Considering these studies, a GWAS approach might not yet yield the most clear
or robust findings. The SNPs uncovered in these two studies seem to be indirectly related
to cannabinoid pharmacology or drug-seeking behaviors. Therefore, as suggested by the
authors, a candidate-gene approach might yield more robust findings until more
individuals with cannabis use disorders become available in GWAS samples (Agrawal &
Lynskey, 2009).
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1.6 Adolescent Brain Development
With the advent of in-vivo human neuroimaging, great strides have been made to
paint a portrait of the human brain as it develops into the adult form. During this period,
the brain undergoes a series of developments including global and focal volume changes,
myelination, synaptic pruning, and receptor proliferation until the stable adult form is
reached in early adulthood (Spear, 2000, 2013). Throughout this process, the neural
architecture supporting cognitive, motor, and sensory functions reach maturity. The
studies to be covered in this section illuminate these structural and functional
developmental processes in light of the behavioral characteristics displayed in
adolescence.

1.6.1 Structural Development
From gestation to late childhood, the human brain generates an excess of neurons
and affiliated synaptic connections in order to supply individuals with an overabundance
of neural resources (Huttenlocher & Dabholkar, 1997; Oppenheim, 1991). Synaptic
pruning is a major aspect of adolescent neurodevelopment. Pruning results in
considerable gray matter volume loss as a healthy means to promote functional neuronal
efficiency. During this process, the important neural connections established from prior
experience and learning are preserved, while redundant connections are terminated. Early
inquiry into adolescent brain development using non-human primate models postulated
that thousands of synapses per second are pruned during the peak of adolescent gray
matter development, with some regions resulting in the loss of nearly half the connections
formed prior to adolescence (Rakic, Bourgeois, & Goldman-Rakic, 1994).
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In addition to synaptic pruning, neuronal myelination, the process by which
neurons become coated in fatty projections from oligodendrocytes, also proliferates
during adolescence. The myelin sheath expedites signal propagation during synaptic
transmission thus allowing distal regions of the brain to communicate more rapidly. In
particular, Paus and colleagues report that adolescent brain development is specifically
characterized by a marked increase in the myelination of the corticospinal tracts
supporting voluntary movements, and the frontotemporal tracts supporting language
(Paus, 1999).
Pruning and myelination processes are especially active in the prefrontal cortex
(PFC) (Gogtay et al., 2004; Whitford et al., 2007), medial temporal lobe structures, and
are orchestrated in part by the endogenous cannabinoid system (Bossong & Niesink,
2010). Studies have shown that exogenous cannabinoids can interfere with the
endogenous system (Hoffman et al., 2007; Mato & Pazos, 2004). Given the natural
maturation occurring in the brain during adolescence and the propensity towards cannabis
use, the consumption of exogenous cannabinoids during adolescence may disrupt typical
neurodevelopment within the cognitive and emotional neural systems. Hence, it is crucial
to investigate the impact of cannabis use on these brain systems. Research on this topic
will be considered in later sections.
In light of these structural changes, males and females exhibit different
neurodevelopmental features. Generally, the most commonly reported sex-difference is
the finding that male brains are between 9-14% larger than female brains (Paus, 2010),
with relatively inconsistent findings for focal volume differences by sex. Pioneering work
by Giedd and colleagues have uncovered divergent neural developmental trajectories for
13

each sex (Giedd et al., 1999). Total brain volume and total gray matter volume (but not
white matter) exhibit an inverted U shape. Volumes increase throughout childhood and
then reaches an inflection point in early adolescence triggering the decline of brain
volume, most likely driven by pruning processes. On average, females reach peak total
brain volume at age 10.5 years while males reach peak total brain volume at age 14.5
years. Research from Lenroot and colleagues suggest that white matter volume increases
steadily throughout the lifespan, but at a much faster rate in adolescence for males than
females (Lenroot et al., 2007). In a related study of white matter development by Perrin
and colleagues, authors postulate white matter sex-differences may be due to axonal
diameter, rather than myelination, as testosterone upregulates expression of microtubules
within the axon (Perrin et al., 2008).

1.6.2 Functional Development
While structural maturity can be tracked via volumetric measurements following
developmental trajectories, it is challenging to assert functional maturity from
neuroimaging studies. Some argue that augmented blood oxygenated level dependent
(BOLD) signal intensity indicates functional immaturity as the neural resources are taxed
to a greater extent, whereas others argue that increased activation is a sign of neural
specialization. Perhaps more important than signal intensity, Durston and colleagues
argue that spatial-extent of activity might be a better characteristic of functional maturity
(Durston et al., 2006). Compared to immature diffuse activity, organized and predictable
focal activation networks may indicate more efficient processing. These networks are
established as a result of neuronal maturation and the strengthening of relevant
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connections via long-term potentiation. As such, spatial-extent is also considered an
important way to characterize functional between-group differences.
During childhood and throughout adolescence, brain activation networks develop
into organized distributed processes favoring sparse “small world” network structures
(meaning spatially distant regions of the brain are connected by a small number of
connections). In a study of resting state network structures by Fair and colleagues, apriori defined regions of interest supporting the default mode network were studied at
two stages of development. Findings indicated that five of the thirteen a-priori regions
modeled as network nodes exhibited weak interconnectivity at age 7, were then followed
by a positive shift to strong interconnectivity by age 21. For instance, correlated activity
between a node in the medial prefrontal cortex and a node in the lateral parietal cortex
was weakly evident in children but later exhibit robust correlated activity in adults. This
example of functional integration among seemingly distant cortical regions is a hallmark
of functional development and reflects mature functional efficiency grounded in the
changes to the structural architecture (Churchwell, Lopez-Larson, & Yurgelun-Todd,
2010; Giedd et al., 1999; Lenroot et al., 2007; Perrin et al., 2008).

1.6.3 Brain Development and Adolescent Behavior
Given the unique profile of adolescent behavior, investigators postulate that there
might be neural correlates supporting these behavioral characteristics. For example, the
increase in reward-seeking behaviors described earlier may be correlated with
neurodevelopmental changes. The current framework of adolescent neurodevelopment in
relation to substance use behaviors postulates that a divergent rate of maturation between
15

the subcortical and prefrontal regions of the brain might drive reward-seeking behaviors.
Previous studies of resting-state functional connectivity between the ventral striatum and
medial prefrontal cortex (mPFC) suggest connectivity differs by age. Children and
adolescents exhibit positively correlated activity between the ventral striatum and mPFC
regions, whereas adults exhibit a developmental switch to anti-correlated activity (Fareri
et al., 2015). This effect is also evident in the connectivity between the amygdala and
mPFC (Gee et al., 2013). As such, anti-correlated activity is interpreted as a sign of topdown cognitive control mechanisms whereby the prefrontal cortex down-regulates
subcortical activity.
Specifically, the bottom-up mesocortical and mesostriatal projections of the
ventral tegmental area achieve functional maturity prior to opposing top-down prefrontal
projections. Animal models indicated mesocortical dopamine projections to the PFC
reach high levels during adolescence (Kalsbeek et al., 1988; Leslie et al., 1991;
Rosenberg & Lewis, 1994). Animal models have also identified the three major
dopamine receptor subtypes, D1, D2, and D4, reach peak concentrations in the striatum
during adolescence, whereas the concentrations in cortical regions continued to rise
throughout adulthood (Tarazi & Baldessarini, 2000). While more research is needed,
functional MRI studies of reward processing have found heightened BOLD signals in the
striatum and ventromedial prefrontal cortex (vmPFC) specific to adolescents during
receipt of reward (Cohen et al., 2010; Leijenhorst et al., 2010). Interestingly, another
study found a positive correlation between this signal and a self-report measure of risktaking behaviors (Galvan et al., 2007). In considering these finding as functional
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significance of a primed dopamine system in adolescence, the striatum may potentiate
teenage reward-seeking behaviors.

1.6.4 Structural Brain Correlates of Adolescent Drug Use
In addition to studying the neural correlates of adolescent behavior, there has been
a considerable amount of research on the neural correlates of drug use. In terms of
structural MRI findings, an early neuroimaging study of adolescent cannabis users failed
to find any gross anatomical differences between users and controls (Block et al., 2000),
however, these findings were underpowered relative to the more recent reports.
The cerebellum and medial temporal lobe structures are especially interesting to
study in the context of cannabis use, given the high amount of primary cannabinoid
receptor (CB1) densities in these regions (Glass, Dragunow, & Faull, 1997), along with
their contribution to cognitive and appetitive behavioral processes. Ashtari and
colleagues identified bilateral hippocampal volume reductions in adolescent cannabis
users compared to controls when scanned after 1 month of monitored abstinence.
Furthermore, self-reported levels of use was inversely correlated with the right
hippocampus, suggesting a dose response in volume reduction (Ashtari et al., 2011).
Similarly, Yücel and colleagues also report gray matter volume (GMV) reductions in the
bilateral amygdala (Yücel et al., 2008). Lastly, in a study of young adults, GMV was
increased in the anterior cerebellum of heavy cannabis users, whereas a negative
correlation between dependency scores and right amygdala GMV, and, weekly cannabis
use and bilateral hippocampal GMV was identified (Cousijn et al., 2012). All authors
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interpret their finding in the context of the CB1 densities in these medial temporal lobe
structures.
As these studies were cross-sectional by design, it is difficult to determine the
causal relationship between cannabis use and structural changes in humans. However, a
longitudinal study by Cheetham and colleagues suggests some volumetric effects might
precede use. Researchers found gray matter reduction in the orbital frontal region at age
12 in those subjects who went on to use cannabis at age 16 (Cheetham et al., 2012).
These findings are intriguing as work by Volkow & Fowler report hypoactivity in orbital
frontal regions using fMRI and PET studies of individuals with drug dependence
(Volkow & Fowler, 2000). Nonetheless, given the lack of subcortical findings in the
Cheetham study, it might be the case that the medial temporal lobe structures are most
sensitive to exogenous cannabinoids.
In light of these studies, the majority of these findings point to a correlation
between volume reduction and cannabis use. Authors provide mechanistic interpretations
using two different strategies. First, if volumetric differences precede drug use as
suggested by Cheetham et al., this might signal evidence of accelerated development as
gray matter pruning completed sooner than their peers. Alternatively, if volumetric
effects are a consequence of use, then cannabinoids might have neurotoxic effects.
Indeed, in a study of cultured hippocampal neurons, researchers observed shrinkage of
cell bodies and nuclei, as well as DNA strand breaks induced by delta-9trahydrocannabinol (THC). However, the authors state their findings may not replicate in
human cells in situ (Chan et al., 1998).
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1.6.5. Functional Brain Correlates of Adolescent Drug Use
Functional neuroimaging inquiries into the neural correlates of adolescent
cannabis use are sparse. One study conducted by the author of this thesis probed for
differences in reactivity to social threats between age 14 cannabis users vs. matched
controls. Findings indicated the cannabis users exhibited greater BOLD signals from the
bilateral amygdala during the viewing of angry faces and thus might characterize teen
cannabis users as hyper-sensitive to signals of threat (Spechler et al., 2015).
In an interesting fMRI study of insular activity, Migliorini and colleagues
pleasantly stimulated regions on the palm and forearm thought to send afferents to the
insula. Investigators had a-priori interest in striatal and insular activity as previous
literature suggests interoceptive dysregulation might promote the initiation and
maintenance of drug-seeking behaviors (Naqvi & Bechara, 2010). In comparison to
adolescents with alcohol and/or cannabis use disorders to matched controls, findings
indicated that drug users exhibit greater activation in the left anterior insula and lentiform
nucleus during soft touch stimulation. However, self-report measures of pleasantness
were inversely correlated with anterior insula BOLD activity, such that lower ratings of
pleasantness was coupled to higher insular BOLD activation, a finding that was
positively correlated in controls. Authors interpret this disconnect between somatic selfreport and neural activation as a sign of body prediction error, whereby the individual
misdiagnoses

internal

states

and

makes

maladaptive

homeostatic

behavioral

modifications through drug consuming and addictive behaviors (Koob & Le Moal, 2008;
Paulus, Tapert, & Schulteis, 2009).
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Work by Tapert and colleagues studied response inhibition in a group of teens
with and without cannabis use histories after 1 month of monitored abstinence. Despite
not observing behavioral task differences, greater diffuse cortical activations during
successful inhibition trials were evident in the cannabis using group. In additional studies
by the same lab, findings follow similar patterns despite using spatial working memory,
and verbal learning tasks. Teen cannabis users failed to exhibit differences on cognitive
task performance after one month abstinence, and were instead better characterized by
diffuse functional brain activations (Norman & Shallice, 1985; Padula, Schweinsburg, &
Tapert, 2007). Similar effects have also been reported from groups outside of the Tapert
lab (Abdullaev et al., 2010; Jager et al., 2010), including one study identifying greater
diffuse activity during a verbal working memory task correlating with earlier age of
cannabis initiation (Becker et al., 2010). The consistency of these effects all offer support
in the interpretation that adolescent cannabis users may have compromised healthy
synaptic pruning during development, thus resulting in inefficient processing capabilities.
However, these interpretations might be flawed given the cross-sectional study design.

1.7 Predictive Modeling of Drug Use
Considering that the majority of work presented above were cross-sectional
studies, it is imperative to conduct more research in order to disentangle cause from
effect. Longitudinal studies are very useful in identifying predictive features and
consequences of drug use, however, these studies are often challenging to complete, and
the analyses are prone to error in methodology and interpretation. Nonetheless, the ability
to predict later drug use would inform targeted clinical interventions designed to curb
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initiation, and subsequently minimize or eliminate negative consequences of use.
Therefore, predictive modeling of drug use needs to be conducted using a set of best
practices in order to have a meaningful impact. In the remaining sections, we will
consider predictive modeling procedures in relation to substance abuse research.

1.7.1. Predictive Modeling Procedures
As outlined by Whelan & Garavan, predictive modeling can be a challenging
pursuit, especially in the field of psychiatric neuroimaging (Whelan & Garavan, 2014).
When using neuroimaging to predict a phenotype, the number of independent variables
(hundreds of regions of interest (ROIs) or thousands of voxels) often exceeds the number
of sample observations, resulting in predictors p >> n observations. In this scenario, when
estimating a typical multiple-regression model (i.e., ordinary least squares for linear
regression; maximum likelihood for logistic regression), model estimation fails to
converge on a single unique solution and results in a perfect fit to the data. In general,
model fit statistics increase as the number of estimated parameters increases, and/or the
number of subjects decreases. In these scenarios, the researcher might be driven to
overoptimistic interpretations and beliefs concerning their results (Whelan & Garavan,
2014).
Importantly, the ultimate goal for predictive modeling aims to yield a model that
will make accurate predictions about novel observations. However, a model estimated on
a dataset where p > n will overfit to the observations and consequently poorly predict the
outcome of a novel or out-of-sample observation. To overcome these challenges, we will
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consider two proposed remedies that can be used in parallel— cross-validation, and
regularization.
Cross-validation is a procedure used to partition the original dataset into
subsamples of observations. A model is then estimated on one subsample of the dataset
(“training data”), and then evaluated using the observations in the subsample not used
(“test data”) during model estimation. Thus, the researcher is able to evaluate how well
their predictive model generalizes to out of sample observations. Generalizability may be
quantified using typical model performance statistics, like R2 for linear models or the area
under the curve of the receiver-operating characteristic (AUC) from logistic models,
returned from evaluating the model on the test data. For these two statistics, values
closer to 1 reflect superior performance.
One specific form of cross-validation is k-fold cross-validation, where k = number
of partitions (or, “folds) of the original dataset. Each fold contains an equal number of
unique samples from the original dataset (i.e., When k = 10 and N=100, each kth fold will
have n=10 observations). k-fold cross-validation then becomes an iterative process
whereby a single fold is set aside as the test sample (“test fold”), and a model is estimated
on the remaining k-1 folds. The model estimated on the k-1 folds is then evaluated on the
set aside test fold, thereby insuring the independence of the final test sample. This
process is repeated k times, resulting in k final models. In doing so, each observation is
tested exactly once, and used in model estimation k-1 times.
Regularization is statistical technique used during model estimation that attempts
to minimize the amount of overfit to the data. Similarly to model estimation using
ordinary least squares, regularized regression techniques seek to minimize the error
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between the predicted and observed outcome while also minimizing the magnitude of the
regression coefficients. Prior to regularization, it is important that all independent
variables are standardized. Here, two specific forms of regularization will be considered,
LASSO (Least Absolute Shrinkage and Selector Operator, (Tibshirani, 1996)) regression,
and Ridge regression (Hoerl & Kennard, 1970).
LASSO regression rejects complex models in favor of parsimonious models by
minimizing the sum of the absolute values of the coefficients during model fit. In doing
so, the LASSO estimator solves for the 𝓵𝟏 -norm of the design matrix. During LASSO
estimation, predictors that are weakly correlated with the outcome measure are assigned a
regression coefficient equal to zero, effectively removing them from the final model. As
such, the predictors that remain in the model are potentially more important to the
outcome measure than the predictors set to zero. Therefore, LASSO regression is one
option available to researchers when p >> n as the estimation procedure performs feature
selection while fitting a model.
Ridge regression seeks to resolve problems arising from multicolinearity among
predictor variables. The Ridge estimator minimizes the sum of the squared values of the
regression coefficients during model fit. In doing so, the Ridge estimator solves for the
𝓵𝟐 -norm of the design matrix. All predictors are estimated but tend to be assigned smaller
coefficients to reduce their fit. As such, correlated predictor variables are given similar
regression coefficients and allowed to coexist in the model. Therefore, Ridge regression
might be especially valuable in modeling inherently correlated predictor variables
common to neuroimaging and psychological research (e.g., neighboring or functionally
co-activating brain data; alcohol and tobacco use levels).
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In cases where p >> n, and modeling correlated variables might be of theoretical
interest, a hybrid approach balancing LASSO and Ridge regression, termed “elastic-net”
regularization (Zou & Hastie, 2005), can be used. In elastic-net regularization, LASSO
and Ridge are combined using a mixing parameter, α that balances the contribution of the
LASSO to Ridge estimation methods. In addition to the α parameter, a second parameter,
λ controls the magnitude of the shrinkage applied to the coefficients.
During elastic-net model estimation, the α and the λ values can be tuned within a
cross-validation procedure in order to identify the optimal set of parameter values that
minimize the test error returned from evaluating model fit on an independent sample of
observations. These tuning parameters are always non-negative values, such that 0 ≤ α ≤
1 and 0 ≤ λ. It can be shown that when α approaches 1, the LASSO estimator is favored.
Likewise, when α approaches 0, the Ridge estimator is favored. Intermediate values of α
provide an interpolation between the two estimation procedures.

Thus, given N

observation pairs (xi, yi) the elastic-net regularization problem for fitting regression
coefficients, β to a linear model is solved from the following Equation 1.1.
Equation 1.1
𝟏
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(𝟏 − 𝜶) 𝟐
𝜷𝒋 + 𝜶 𝜷𝒋
𝟐

1.7.2. Predictive Modeling of Binge-Drinking by Age 16
In a study related to the empirical work described later in this thesis, Whelan and
colleagues implemented many of the procedures described above to classify adolescent
binge-drinkers at age 14, and, predict binge-drinking by age 16 from data collected age
14. In applying these methods to a wealth of neuroimaging, psychometric, and candidate
SNP data, findings indicated a high degree of predictive modeling performance
(classification AUC=0.90; prediction AUC=0.75). Specifically, the most reliable features
that both classified and predicted adolescent binge-drinking were more frequent sexual
life experiences and similar personality traits including elevated novelty-seeking,
disorderly, and extravagant personalities, and diminished conscientiousness traits. The
reliable brain features contributing to classification of age 14 binge drinking included
reduced GMV of the vmPFC, and reduced BOLD activity in key subcortical regions
including the left putamen and hippocampus during reward anticipation, and right
hippocampus during reward outcome. The reliable brain features contributing to age 16
prediction involved reduced BOLD activity in pre- and post-central gyri during failed
response inhibitions. Interestingly, classification was driven by blunted activity in regions
serving appetitive processing during a reward task, while prediction was driven by
blunted activity in a motor area during failed response inhibitions. Indeed, this study
inspired the theory and methodological undertakings of the empirical work to be
presented in the following chapter.
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Chapter 2: Predicting Cannabis Use in Adolescent Males and Females from
High-dimensional Biobehavioral Data
2.1 Introduction
Studies suggest cannabis use during adolescence is associated with a range of
adversity in adulthood including cannabis use dependence (Hall & Degenhardt, 2009),
polydrug use (Secades-Villa et al., 2015), cognitive deficits (Meier et al., 2012; Schuster
et al., 2016), compromised physical (Kalant, 2004) and mental health (Degenhardt et al.,
2013; Kedzior & Laeber, 2014; Malone, Hill, & Rubino, 2010), and diminished life
attainment goals (Fergusson & Boden, 2008). These findings are supported by animal
models linking cannabis exposure during adolescence with detrimental outcomes in
adulthood (O’Shea, 2004; Quinn et al., 2008). However, in humans, it is notoriously
difficult to assert a causal role for cannabis in subsequent outcomes. As drug users selfselect into use, any negative outcomes arising from use could be related to a number of
factors that are confounded with the choice to initiate and continue cannabis use (Jackson
et al., 2016).
As indicated from the 2013 National Survey on Drug Use and Health, rates of
cannabis use in adolescence are high as nearly 25% of all 10th graders now report trying
the drug (2014). In parallel, from 2005 to 2010, rates of cannabis-related emergency
room visits has increased 54% in males and 42% in females aged 15-17 years (2014).
Moreover, beliefs concerning the risk of use are declining (Johnston et al., 2011) despite
the considerable increase in drug potency compared to previous decades (ElSohly et al.,
2016). These findings are a source of concern as in vitro models indicate that delta-9tetrahydrocannabinol (THC), the key psychoactive compound of cannabis, could be more
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toxic in adolescent than in adult tissue (Pope et al., 2003; Quinn et al., 2008; Renard et
al., 2016; Rubino et al., 2015; Schneider, 2008), and studies in humans suggest that early
initiation of cannabis is associated with deleterious outcomes compared to delayed onset
users (Brook et al., 2011; Coffey & Patton, 2016).
Longitudinal studies of adolescent development suggest cannabis use is typically
initiated between the ages of 16-18 (Chen & Kandel, 1995). Thus, adolescence might be
a developmental phase during which initiation can be best predicted and, consequently,
might yield occasions for preventative interventions. Indeed, characterizing the
individuals who are most likely to initiate drug use can give insights into the risk factors
for use and thereby inform etiological mechanisms.

With recreational cannabis

legalization efforts sweeping the United States and abroad, there is an added imperative
to identify which adolescents are most at risk for initiation of use in order to curb any
consequences of adolescent exposure.
Here, we seek to uncover risk profiles that predict the initiation of cannabis use in
adolescence. Participants (N=1,389; see table 2.1.1 for demographics) from the IMAGEN
study (Schumann et al., 2010) were characterized across three domains— psychometric,
genetic (single nucleotide polymorphisms, SNPs), and brain data (see table 2.1.2 for
summary). Data were submitted to a retrospective longitudinal analysis such that the
outcome measure, cannabis use by age 16, was predicted from data across all three
domains measured at age 14 prior to any cannabis exposure. Cannabis use by age 16 was
determined from a self-reported drug use questionnaire. Participants who endorsed using
cannabis greater than or equal to six times by age 16 were assigned to the outcome group,
as these individuals have used cannabis beyond experimentation levels. All participants
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reported no cannabis use at age 14 and those who also endorsed no cannabis use by age
16 were assigned to the comparison group.

2.1.1. Participant Demographics
Groups
Males

Females

Measure
Cannabis Use
by Age 16
(n=110)

Comparison
Group
(n=538)

p

Cannabis Use
by Age 16
(n=63)

Comparison
Group
(n=678)

p

Age (M,SD)

14.49, 0.50

14.52, 0.39

.511

14.50, 0.53

14.54, 0.42

.518

Handedness (L,R)

11, 99

66, 472

.503

7, 56

60, 618

.549

PDS (M,SD)

2.63, 0.48

2.54 , 0.55

.114

3.23, 0.35

3.17, 0.44

.266

Perceptual IQ
(M,SD)

108.30, 13.89

108.18, 14.56

.938

106.56, 13.31

107.77, 13.23

.487

Verbal IQ (M,SD)

115.45, 11.97

112.07, 13.14

.013

111.75, 11.86

109.22, 13.80

.159

SES (M,SD)

18.92, 3.92

17.88, 3.82

.010

17.60, 4.0

17.88, 3.68

.567

Table 2.1.1: PDS: Puberty Development Scale (Petersen et al., 1988). ESPAD: European
School Survey Project on Alcohol and Drugs (Hibell et al., 1997). SES: Socioeconomic
Status.
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2.1.2 Summary of Data
Domain

Psychometric

Genetic

Structural
Neuroimaging

Functional
Neuroimaging

Measures
•
•
•
•
•
•

Demographics
Cognitive assessments
Personality assessment
Life-events questionnaires
Baseline cigarette & alcohol use
Parent personality and drug use

• A-priori SNPs
• Cannabinoid Receptor
• Catecholamine Receptors
• Opioid Receptors
• Total GMV
• Gray-Matter Volume ROIs
• Reward Processing Task
• (2 Contrasts)
• Stop Signal Task
• (2 Contrasts)
• Face Processing Task
• (3 Contrasts)
Predictors per subject

Data points

• 80 measures

• 108 SNPs

• 1 total GMV
• 278 GMV ROIs

• 1946 ROIs
• 278 per contrast

2413

Table 2.1.2: Summary of data used in predictive modeling. A related analysis including
psychopathology measures was conducted but did not improve predictive performance.
See supplemental text for details regarding each measure. Site was modeled in the
analysis and yielded Paris (data not shown) as a significant predictor due to the higher
base rate of age 16 cannabis use for both sexes.

Given the challenges of predictive modeling in psychiatric neuroimaging (Whelan
& Garavan, 2014), we utilize practices from the field of machine learning to ensure our
predictive modeling efforts guard against overfitting, generalize to out-of-sample
observations, and select the most predictive variables from a large feature space (p =
2,413). Thus, 10-fold cross-validated logistic regression with nested elastic-net
regularization (Zou & Hastie, 2005) was implemented. Predictive model performance
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was assessed using the area under the receiver-operating characteristic curve (“ROC
AUC”) returned when evaluating the estimated training models on the set-aside test-folds
during the cross-validation scheme. As neuroimaging and psychometric profiles of
adolescents exhibit clear sex differences, these analyses were executed separately for
each sex. Hence, we report sex-specific predictive models of the initiation of cannabis
use in adolescence.

2.2 Predictive Modeling Performance
The male-specific analysis returned a mean ROC AUC=0.71 (σ =.02, p < 1.92 x
10-12 ; see figure 2.2.1), while the female-specific analysis returned a mean ROC
AUC=0.81 (σ =.02, p < 1.99 x 10-16 ; see figure 2.2.1). The superior prediction for
females is notable given that they were fewer in number and lighter in use compared to
males (Tables 2.1.1 & A1.4). To assess the impact that the differences in sample size and
use severity might have on modeling, an analysis conducted on a smaller number of
males, matched on sample size and use levels to the female cohort, was shown to worsen
the prediction for males (mean ΔAUC= -.08 relative to full male sample). Thus, the
superior prediction of cannabis use in the female sample indicates that females exhibit a
more distinct profile at age 14 relative to their non-using peers.
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2.2.1 ROC Curves by Sex
1

True positive rate
(sensitivity)

1

Females:
AUC = 0.81, p < 1.99 x 10-16

Males:
AUC = 0.71, p < 1.92 x 10-12
0

False positive rate
(1 – specificity)

1

0

False positive rate
(1 – specificity)

1

Figure 2.2.1: Visualizing the performance of the predictive model on
independent observations. Representative of the mean AUC across 100 runs for each sex.
.
2.3 Predictive Features
The analyses identified seven psychometric predictors of cannabis use by age 16
common to both sexes including greater lifetime alcohol and cigarette use by age 14,
parental lifetime cannabis use, greater novelty-seeking personality and the disorderliness
personality subscale (Cloninger, 1999), and, more frequent sexual and distressful life
events (See figure 2.3.1 & 2.3.2). These seven shared psychometric predictors replicate
previous findings, as alcohol and nicotine use are well-established predictors of cannabis
use (Hall & Pacula, 2003; Siegel et al., 2014), as are stressful (Sinha, 2008) and sexual
(Cornelius et al., 2007) life events, parental transmission of drug use (Brook et al., 2001;
Kandel, Kessler, & Margulies, 1978; Kosty et al., 2015), and novelty-seeking personality
and the disorderliness subscale (Hale et al., 2003; Mccormick et al., 1998; Sher & Trull,
31

1994). Taken together, this psychometric profile suggests that behaviorally disinhibited
lifestyles precedes cannabis use as these teens exhibit more risky and novelty-seeking
behaviors by age 14 compared to their non-using peers.
2.3.1 Shared Psychometric Predictors of Cannabis Use by Age 16: Drug Use
Measures
Frequency of Lifetime Nicotine Use

Frequency of Lifetime Alcohol Use

4
4

Lifetime Alcohol Use
by Age-14
(mean)
3

3

1
3
Comparison Group
Age-16 Cannabis User

Cannabis Use by Age-16

2
2

1

Mean imp4_espad_24a_parent

Mean imp4_ESPAD_6

Mean imp4_ESPAD_8A

3

2

0

Males
Males

Females
Females

sex

1

0

2

1

1

0

1
Comparison Group
Age-16 Cannabis User

2

2

1

0

1

3
Comparison Group
Age-16 Cannabis User

Comparison Group
3

Frequency of Parental Cannabis Use
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Figure 2.3.1: All measures from the ESPAD (Hibell et al., 1997). Drug use measured on
an ordinal scale (0=0, 1=1-2x, 2=3-5x, 3=6-9x). Green bars represent participants (or the
parents of the participants) using cannabis at age 16, blue bars represent non-using
participants (or parents). Error bars represent the standard error of the mean.
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2.3.2 Shared Psychometric Predictors of Cannabis Use by Age 16: Life Events &
Personality
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Figure 2.3.2: Top row: from the Life Events Questionnaire (LEQ, (Newcomb et al.,
1981)) and represents the mean frequency of endorsing a life event pertaining to either
distressful or sexual experiences. Data measured on a binary scale (1=Yes). Bottom row:
from the Temperament and Character Inventory (TCI, (Cloninger, 1999)), and represent
the sum score of items related to disorderly or novelty-seeking personality traits. Data
measured on an ordinal scale (5=definitely true, 1=definitely false). Green bars represent
subjects using cannabis at age 16, blue bars represent non-using subjects. Error bars
represent the standard error of the mean.
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Male-specific psychometric predictors
of cannabis use by age 16 included
less-

negative feelings towards deviant behaviors, and greater parental novelty-seeking
personality and the excitability personality subscale (Cloninger, 1999). Less-negative
feelings towards deviant behaviors in the males may signal a slight predisposition
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towards delinquency and conduct problems in these adolescents. While previous studies
have identified a correlation between problematic conduct and cannabis use (Crowley et
al., 1998; Robins & McEvoy, 1990), our findings suggest that a predisposition towards
problematic conduct might be a target of proactive intervention. Moreover, although
personality traits are highly heritable, the novelty-seeking personality traits of both the
parent and son independently predicted cannabis use by age 16 (post-hoc partialcorrelation between the outcome measure and child novelty-seeking personality r645 =
.17, p < .001, after first accounting for parent novelty-seeking personality, r648 = .12, p <
.005).
Female-specific psychometric predictors of cannabis use by age 16 included
greater extravagant personality subscale (Cloninger, 1999) in both the parent and
daughter. As was the case with males, the heightened extravagant personality subscale of
both the parent and daughter made separate contributions to the prediction (post-hoc
partial-correlation between the outcome measure and child extravagant personality r738 =
.15, p < .001, after first accounting for parent extravagant personality r741 = .08, p < .05).
Additionally, greater parental impulsive personality subscale (Cloninger, 1999) was
identified as a predictor.
In considering the parental influence of cannabis use in their offspring, parents with
behaviorally disinhibited personality features, coupled with a history of cannabis use,
were found to confer risk of use to their children. Recent work by Kerr and colleagues
corroborate these findings as they report that adolescents have increased risk of cannabis
use when raised by parents who use cannabis and have diminished monitoring of their
children (Kerr et al., 2015).
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In the male sample, three brain activation measures pertaining to the motor response
inhibition (“stop signal”) task were found to reliably predict cannabis use by age 16.
Relative to the comparison group, lower activation during successful response inhibitions
in the left paravermis and the posterior-lateral part of the left hemisphere of the
cerebellum, and, lower activation during failed response inhibition in the right inferior
temporal gyrus, all predicted cannabis use by age 16 in males (see figure 2.3.3 & 2.3.5).
Animal models using neuronal tracers suggests that the lateral cerebellum is involved in
motor preparation and inhibition via projections to cortical motor and inhibitory regions
through the thalamus (Middleton & Strick, 2001). These regions have also been
previously identified as participating in a network underlying motor inhibitory control
(Stevens et al., 2007). Thus, hypoactivity in these cerebellar regions underlying inhibitory
control suggests that diminished recruitment of cerebellar motor resources might have
behavioral consequences for adolescent males.
As these findings were evident prior to cannabis use initiation, a compromised
motor inhibitory control system at age 14 might constitute a neurobiological vulnerability
and promote the initiation of drug-consuming behaviors by age 16 in males. Moreover,
the right inferior temporal region is considered part of the visual processing stream and
has been previously associated with greater activity during stop failures (Hu & Li, 2012).
Therefore, hypoactivity in this region correlating with failed response inhibitions might
suggest cannabis use by age 16 in males is predicted by impaired processing of visual
stop signal cues in their environment.
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2.3.3 Male Brain Predictors

Stop Success†
Stop Failure†

L
R
†
Cannabis < Controls , p < .05

Figure 2.3.3: Lower activation in three regions predicts cannabis use by age 16 in males.
Stop Success relates to successful inhibition trials minus implicit baseline during the stop
signal task. Regions of interest (ROI) in left cerebellum include the left paravermis, and
posterior-lateral part of the left hemisphere. Stop failure relates to failed inhibition trials
minus implicit baseline during the stop-signal task. ROI in right inferior temporal gyrus.
†

2-sample t-tests on participants endorsing cannabis use by age 16 vs. their non-using
controls confirms significant differences in activations.
In the female sample, four brain measures were found to reliably predict cannabis
use by age 16. Relative to the comparison group, higher activation during failed response
inhibition in the right pre-supplementary motor area (pre-SMA) predicted female use. In
this same region, larger gray matter volume relative to the comparison group also
predicted cannabis use. As cortical myelination proliferates during adolescence,
especially in motor areas requiring expedited signal propagation (Paus, 1999), these
structural-functional findings suggest a functional consequence of delayed cortical
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maturation. This structural finding is notable for the female sample as cortical maturation
occurs earlier in adolescent females compared to their male peers (Giedd, 2004). As
such, a larger gray matter volume might influence the observed higher activity of the
motor system, which in turn, jeopardizes inhibitory control.
Dissimilar to males, the females exhibited activation differences when processing
social stimuli. Specifically, when viewing neutral faces, cannabis users by age 16 had
higher activation in the right anterior inferior temporal lobe and lower activation in the
right lingual gyrus of the visual cortex (see figure 2.3.4 & 2.3.5). As these two regions
have previously been established in the processing of face stimuli (Britton et al., 2006;
Loughead et al., 2008), these findings highlight female sensitivity to social stimuli and
implicate these processes in a predisposition towards cannabis use. In light of these
findings, face processing studies suggest neutral faces can be misperceived as
threatening, especially in individuals with social anxiety disorder (Cooney et al., 2006;
Yoon & Zinbarg, 2008). Given the higher prevalence of social anxiety in females
(Schneier, 1992) and the correlation between social anxiety and prevalence of cannabis
use in females (Buckner et al., 2006, 2007) the results point to a female-specific pathway
towards cannabis use.
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2.3.4 Female Brain Predictors

Stop Failure & GMV*
Neutral Faces*
Neutral Faces†

L

R

* Cannabis > Controls , p < .05
† Cannabis < Controls , p < .05

Figure 2.3.4: Activations and structural differences in three regions predicts cannabis use
by age 16 in females. Stop failure relates to failed inhibition trials minus implicit baseline
during the stop-signal task. Region of interest (ROI) in right pre-supplementary motor
area. GMV measures gray-matter volume. ROI in right pre-supplementary motor area
(identical ROI with stop failure). Neutral Faces relates to passive viewing of neutral
faces minus control images during the face task. ROIs in right anterior inferior temporal
gyrus and lingual gyrus (visual cortex).
*†

2-sample t-tests on participants endorsing cannabis use by age 16 vs. their non-using
controls confirms significant differences in activations and GMV.
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2.3.5 Correlations Between Identified Predictors and Outcome Measure
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Figure 2.3.5: Pearson’s point-biserial correlation (r) between predictor and outcome.
Error bars represent 95% confidence intervals generated from 5000 bootstrap samples.
Circles = Drug use (ESPAD, (Hibell et al., 1997)). Squares = Life Events (LEQ,
(Newcomb et al., 1981)). Deviant life events in males relates to reported positive feelings
towards deviant behaviors. Sex & distressful life events relates to the lifetime frequency.
Triangles = personality (disorderly, extravagant, and impulsive personality are subscales
of the TCI novelty-seeking personality scale, (Cloninger, 1999)). Diamonds =
Neuroimaging data

2.4 Sex- and Drug-specificity of Brain Features
Given the observed sex differences and the known sexual dimorphisms in brain
structure and function, we assessed the sex-specificity of the brain findings. To do so, we
tested how well the brain measures identified to predict cannabis use for one sex
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performed for the other sex. To assess drug-specificity, these predictors were then used to
model binge drinking by age 16 (defined as a minimum of three lifetime binge drinking
episodes by age 16) in a separate sample of 14 year olds (Whelan et al., 2014).
Overlapping participants identified as cannabis users and binge drinkers by age 16 were
excluded from the binge drinking sample (N=436; n=89 of whom transitioned to binge
drinking by age 16). Sex- and drug-specificity model fit was assessed using a chi-square
goodness of fit statistic and the delta-Akaike information criterion (ΔAIC) of model
selection (Akaike, 1974). Model fit statistics were generated by comparing the relative
change in model fit between a model estimated using only the base rate of cannabis use
(or binge drinking) and a model estimated using only the features identified from the
preceding prediction analyses.
As anticipated, post-hoc logistic regressions confirmed that the male-specific
brain predictors of cannabis use returned strong model fits relative to the base rate model
when estimated on the entire male sample (χ23,N=648 = 28.6, p < .001; base rate model
ΔAIC = 22.6 relative to the model with predictors). However, when estimated on the
entire female sample, the model using the male-specific brain predictors is worse than the
base rate model in predicting cannabis use (χ23,N=741 = 2.3, p > .05; model with predictors
ΔAIC = 3.7 relative to the base rate model). These regions were also found to be specific
in their prediction of cannabis as they returned poor model fits in a logistic regression
predicting binge drinking in males (χ23,N=206 = 2.0, p > .05; model with predictors ΔAIC =
4.0 relative to the base rate model).
Post-hoc logistic regression confirmed that the female-specific brain predictors of
cannabis use returned strong model fits for the female sample (χ24,N=741 = 48.5, p < .001;
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base rate model ΔAIC = 40.5 relative to the model with predictors). However, when
estimated on the entire male sample, the model using the female-specific brain predictors
failed to predict cannabis use in males (χ24,N=648 = 2.2, p > .05; model with predictors
ΔAIC = 5.8 relative to the base rate model). Likewise, these regions were found to be
specific in their prediction of cannabis as they returned poor model fits when used to
predict binge drinking in females (χ24,N=230 = 0.45, p > .05; model with predictors ΔAIC
= 7.5 relative to the base rate model). See table 2.4.1 for post-hoc regression summaries.
2.4.1 Post-hoc Regression Model Summaries

Cannabis Predictive
Features

Test Sample
Sex-Specificity

Female Brain
Features

Male & Female
Shared
Genetic Features

Drug-Specificity
Males & Females:
Binge Drinking

Male & Female
Shared Psychometric
Features

Male Brain
Features

Model Fit

Females:
Cannabis Use
Males:
Binge Drinking
Males:
Cannabis Use
Females:
Binge Drinking
Males & Females:
Cannabis Use

Males & Females:
Binge Drinking

χ2,

p

ΔAIC*

74.6, p < .01

32.05 (base rate model –model with predictors)

2.3, p > .05

3.7 (model with predictors –base rate model)

2.0, p > .05

4.0 (model with predictors –base rate model)

2.2, p > .05

5.8 (model with predictors –base rate model)

0.45, p > .05

7.5 (model with predictors –base rate model)

14.8, p < .01

8.8 (nuisance model –model with predictors)

7.8, p = .05

1.8 (nuisance model –model with predictors)

Table 2.4.1: Features identified from each cannabis predictive modeling scenario were
used to probe sex- and drug-specific effects. Male & Female shared psychometric and
genetic predictors of cannabis use by age 16 also predicted binge drinking by age 16.
Male brain predictors and female brain predictors of cannabis use by age 16 failed to
predict cannabis use in the opposite sex, or, binge drinking by age 16 in the same sex.
*ΔAIC always in reference to the better fitting model. ΔAIC= AICmodel_i – AICmin and
reflects the relative increase in information gained from the AICmin (better) model. Values
>=2 favor the AICmin model.
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2.5 Genetic Predictors
The sex-specific analyses did not identify any predictive SNPs, therefore we
collapsed across sex and reran the analysis with only the genetic predictors (plus nuisance
covariates). This analysis returned a mean ROC AUC=0.60 (p < 3.0 x 10-4; see figure
2.5.1), however, the genetic multidimensional scaling factors plus demographic
covariates inflated model performance and the predictive genes were less consistently
selected across the generated models. With that in consideration, a lower threshold (see
supplemental information) identified two SNPs on genes coding for the µ1-opioid
receptor and one on a gene coding for the δ1-opioid receptor. The minor alleles of the two
µ1-opioid receptor SNPs (rs511420, rs1074287) were found to impart genetic risk as a
greater number of the age 16 cannabis users had the minor allele, whereas the minor
allele of the δ1-opioid receptor SNP (rs2236857) was found to impart a protective effect
as its frequency was higher in the comparison group. See table 2.5.2 for the three SNP
statistics including their correlation with the outcome measure.
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2.5.1 ROC Curve for Gene-specific Analysis

True positive rate
(sensitivity)

1

0

False positive rate
(1 – specificity)

1

Figure 2.5.1: Visualizing the performance of the predictive model on independent
observations. Representative of the mean AUC across 100 runs.

2.5.2 Statistics and Frequencies for Cannabis Predictive SNPs
Locus

Gene

HW P
value

MAF

Major:
Minor
Alleles

Imputation
Quality
(R2)

Association
with age 16
Cannabis Use
r

p

Genotype
(% Hminor : HT : Hmajor)
Cannabis Use
by age 16

Comparison
Group

Minor
Allele
Effect

rs511420

OPRM1

.87

0.097

T:C

0.999

-.052

.051

2:19:79

1:15:84

Risk

rs1074287

OPRM1

.90

0.256

A:G

0.991

-.058

.030

10:35:55

7:30:63

Risk

rs2236857

OPRD1

.89

0.266

T:C

1
(Genotyped)

.053

.048

4:30:66

5:37:57

Protection

Table 2.5.2: Measures of Hardy-Weinberg Equilibrium (HW), Minor Allele Frequency
(MAF). Association with cannabis use by age 16 calculated using Spearman’s rank
correlation between SNP and the outcome measure. Hminor: Homozygote minor (highrisk genotype), HT: heterozygote (intermediate-risk genotype), Hmajor: Homozygote major
(low-risk genotype).
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When including these three SNPs in a post-hoc hierarchical logistic regression
predicting cannabis use, the model exhibits strong fit to the full sample after first
modeling the nuisance covariates (Δχ23,N=1389 = 14.8, p < .005; nuisance covariates model
ΔAIC = 8.8 relative to the model with nuisance covariates and SNPs). Likewise,
including these three SNPs returned marginally adequate fits to the full sample of binge
drinkers after first modeling the nuisance covariates (Δχ23,N=436 = 7.8, p = .05; nuisance
covariates model ΔAIC = 1.8 relative to the model with nuisance covariates and SNPs).
Thus, these SNPs might weakly generalize to predict binge drinking by age 16, however,
the model fits effect sizes are far greater in their prediction of the cannabis using sample.
The cannabinoid and opioid neurotransmitter systems have been found to colocalize in the striatum (Rodriguez, Mackie, & Pickel, 2001) and exhibit reciprocal
signaling (Robledo et al., 2008). However, the biobehavioral effects orchestrated by
these systems remain unclear in humans. Animal models suggests the µ-opioid (but not δ)
receptor is specifically involved in reinforcement properties as µ-opioid receptor
knockout mice failed to exhibit THC-induced conditioned place preference compared to
δ-knockout and wild-type mice (Ghozland et al., 2002). Hence, our findings that cannabis
users by age 16 had a greater number of risk alleles for the µ-, but not δ-receptor SNPs
might signal alterations to their neurobiological processing of rewards. Additionally, SNP
rs511420 has previously been identified to interact with stressful life events to promote
depressive symptoms in African-American adolescents (Swann et al., 2014). Therefore,
adolescents who experience life stress and possess the high-risk allele are at an elevated
likelihood to experience depressive symptomology and potentially self-medicate with
cannabis for the phasic anxiolytic and euphoric effects of the drug.
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2.6 Domain-Specific Effects
To investigate the contribution of each domain in the prediction of adolescent
cannabis use, post-hoc hierarchical regressions were conducted to measure the relative
change in model fit after the inclusion of each domain-specific set of predictors. In the
male sample, the psychometric predictors were entered first and significantly improved
model fit relative to the base rate model (χ210,N=648 = 105.31, p < .001; base rate model
ΔAIC = 85.31). The brain predictors were then included and significantly improved
model fit relative to the psychometric predictors model (Δχ23,N=648 = 19.7, p < .01;
psychometric model ΔAIC = 13.71). Finally, the three SNPs were added but did not
improve model fit (Δχ23,N=648 = 4.73, p > .05; model with SNPs ΔAIC = 1.27 relative to
psychometrics and brain model).
Likewise, for the female sample, the psychometric predictors were entered first
and significantly improved model fit relative to the base rate model (χ210,N=741 = 97.33, p
< .001; base rate ΔAIC = 77.3). Next, the brain predictors were included and significantly
improved model fit relative to the psychometric predictors model (Δχ24,N=741 = 43.24, p <
.01; psychometric model ΔAIC = 35.24). Lastly, the three SNPs were included but did
not significantly improve model fit (Δχ23,N=741 = 6.65, p > .05; psychometrics and brain
model ΔAIC = 0.65). For both sexes, the results of the domain-specific hierarchical
regressions held irrespective of the order in which each domain were entered. Thus, while
psychometric data alone can be used to significantly predict cannabis use by age 16,
models containing both psychometric and sex-specific brain features return superior fits,
highlighting their utility of capturing individual differences in the neurobiology
predicting adolescent cannabis use.
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2.7 Conclusions
These analyses have identified individual differences at age 14 that predict
cannabis use two years later. Despite having information on thousands of multi-modal
variables per individual, prediction with high generalizability was achieved with fewer
than fifteen psychometric and brain measures. Some of these individual differences were
specific to predicting cannabis use in each sex while others predicted both cannabis and
binge drinking across the sexes. The generality of the psychometric variables gives some
insights into what might be general risk factors associated with teenage substance use
initiation. Moreover, results revealing that the brain predictors differ between the sexes
underscore the importance of attending to sex-differences in addiction research. Indeed,
the distinction in functional tasks observed for each sex highlights the sex-specific
psychological processes (inhibitory control in males; social processing in females)
potentially driving the initiation of cannabis use in adolescence.
Given the increased availability of cannabis that is likely to accompany ongoing
public policy efforts towards recreational legalization, a potential concern is an increase
in the rates of teenage consumption.

Understanding the individual differences that

predict use offers insights into the etiological mechanisms underlying that use, and
provides knowledge that could guide interventions aimed at reducing any potential
negative consequences on the brain and behavioral health of adolescents.
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Appendix 1: Supplemental Information
A1.1 Schematic of Analytic Method
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Figure A1.1: Schematic of Analytic Method. First, data are divided into k(10) outer-folds.
k-1 outer-folds are then divided into k(10) nested-folds. Elastic-net regularized logistic
regression applied to k-1 nested-folds, during which the α , λ parameters are tuned by
finding the optimal pair returning the highest AUC when it’s model is tested on the k-1
nested-fold. The iterative process is completed for the k(10) nested-folds, generating 10
final nested models. The 10 nested models are ranked by their AUC returned when tested
on each respective k-1 nested test fold. The highest-ranking model is then tested on the
outer fold, and used to generate the reported test AUC. This entire process is repeated ktimes.
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A1.2 Analysis of Head Motion

Task

Mean Framewise Displacement:
Age 16 Users vs. Comparison Group

Faces

t624= 0.55, p > .05

MID

t594= 0.78, p > .05

Stop Signal

t580= -1.5, p > .05

Faces

t712= -1.48, p > .05

MID

t685= 0.43, p > .05

Stop Signal

t678= -0.18, p > .05

Sex

Males

Females

Table A1.2: Framewise displacement was calculated from the six-directional head motion
parameters estimated during image realignment. 2-sample t-tests on the participants
endorsing cannabis at age 16 vs. their non-using peers failed to detect significant
differences in head motion (mean FD) for any of the tasks for either sex.
A1.3 Binge Drinking Sample Demographics

Groups
p

Measure

Binge Drinkers
by age 16 (n=89)

Comparison
Group (n=347)

Age (M,SD)

14.54, 0.45

14.47, 0.39

.133

Sex (Males, Females)

48, 41

158, 189

.190

Handedness (L,R)

10 , 79

40, 307

.999

PDS (M,SD)

3.55, 0.69

3.50, 0.80

.573

Perceptual IQ (M,SD)

106.30, 13.30

107.65, 14.26

.419

Verbal IQ (M,SD)

110.87, 13.98

109.41, 13.58

.396

SES (M,SD)

17.62, 3.92

18.00 , 3.68

.399

Table A1.3: A sample of binge-drinkers by age 16 and never-binge-drinkers comparison
group. Group differences assessed using two-group t-tests on the continuous measures,
and chi-square tests on the categorical measures. PDS: Puberty Development Scale
(Petersen et al., 1988). SES: Socioeconomic Status.
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A1.4 Cannabis Use Levels

Lifetime
Cannabis Use

Males
(n)

Females
(n)

6-9 joints

26

19

10-19 joints

24

20

20-39 joints

23

9

40+ joints

37

15

Total Users

110

63

Comparison Group
Sum

538
678

678
741

Table A1.4: Levels of cannabis use at age 16 by sex. Comparison group contained
individuals who report using no cannabis at age 14 or 16.
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A1.2 Materials and Methods

Supplemental Materials
Materials and Methods
Overview of IMAGEN protocols
Full details of the procedures employed by the IMAGEN study (Schumann et al., 2010),
including details on ethics, recruitment, standardized instructions for administration of
the psychometric and cognitive behavioral measures, and for blood collection and storage
are available to view in the Standard Operating Procedures for the IMAGEN project
(http://www.imagen-europe.com/en/Publications_and_SOP.php).
Participants
Data were acquired from 14-year-old adolescents recruited according to the standard
IMAGEN operating procedures cited above. After complete description of the study to
the

participants

and

their

parents/guardians,

written

informed

consent

was

obtained. Individuals who provided assent completed an extensive battery of
neuropsychological, clinical, personality and drug use assessments online and at the
testing centers. Additional assessments were conducted at age 16. Participants were
excluded if they had contraindications for MRI (metal or electronic implants and
claustrophobia) or problematic medical history (diabetes, tumors, heart defects, etc.),
neurological conditions (epilepsy, head trauma, neurodevelopmental disorders, etc.) or
low IQ.
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Participants were included in the analysis based on the self-report drug use questionnaire
(ESPAD, described below). All participants in the analysis were cannabis naïve at age 14
(N=1389, of whom n=173 transitioned to use by age 16; see table 2.1.1 for
demographics). Age 16 cannabis use was defined as using the drug at least six times by
age 16. This threshold was used in order to identify youths who have initiated cannabis
use beyond experimentation levels.
Data
All data (see table 2.1.2) in the analysis were collected at age 14 and used to predict the
onset of cannabis use by age 16. Questionnaires surveying child and parent personality,
stressful life events, drug use, and cognitive performance comprised the psychometric
data.
Genetic data were comprised of 108 a-priori SNPs of interest coding for neurotransmitter
receptors (cannabinoid, opioid and catecholamines), related enzymes (FAAH), eight
SNPs previously associated with cannabis dependence (Hartman et al., 2009; Hopfer et
al., 2006; Hurd et al., 2014), and one genetic risk-score (Cornelis, 2009) computed from
those 8 SNPs.
Brain data comprised of functional and structural neuroimaging measures parcellated into
278 regions of interest (ROIs) (Shen et al., 2013). Measures include total and regional
gray matter volumes and brain activation associated with response inhibition (assaying
cognitive control systems), reward anticipation and receipt (assaying brain reward
systems) and viewing neutral and angry faces (assaying social processing brain systems).
At each gray matter volume ROI, the ratio of regional to total gray matter volume was
calculated for each subject in order to account for anatomical variability across subjects.
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Structural MRI
High-resolution anatomical magnetic resonance images were acquired, including a 3D
T1-weighted magnetization prepared gradient echo sequence based on the ADNI protocol
(http://www.loni.ucla.edu/ADNI/Cores/index.shtml). Structural MRI processing included
data segmentation and normalization to the Montreal Neurological Institute template
using the SPM optimized normalization routine. Gray matter images were modulated,
thus facilitating comparisons of volumetric, rather than tissue concentration, differences
(Ashburner & Friston, 2000).
Functional MRI
Full details of the magnetic resonance imaging (MRI) acquisition protocols and quality
checks have been described previously, including an extensive period of standardization
across MRI scanners(Schumann et al., 2010). MRI Acquisition Scanning was performed
at the eight IMAGEN assessment sites (London, Nottingham, Dublin, Mannheim,
Dresden, Berlin, Hamburg, and Paris) with 3T whole body MRI systems made by several
manufacturers (Siemens: 4 sites, Philips: 2 sites, General Electric: 1 site, and Bruker: 1
site). To ensure a comparison of MRI data acquired on these different scanners, we
implemented image acquisition techniques using a set of parameters compatible with all
scanners that were held constant across sites, for example, those directly affecting image
contrast or fMRI preprocessing. Site was dummy-coded for use in the machine learning
procedure.
Standardized hardware for visual and auditory stimulus presentation (NordicNeurolabs,
Bergen Norway, http://www.nordicneurolab.com) was used at all sites. BOLD functional
images were acquired with a gradient-echo echo planar imaging (EPI) sequence using a
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relatively short echo-time to optimize imaging of subcortical areas (details of sequence
parameters for structural and functional imaging, and the neuroimaging tasks are given in
Ref. 1). Briefly, the functional imaging processing was as follows: Time series data were
first corrected for slice-timing, then corrected for movement, non-linearly warped onto
MNI space using a custom EPI template, and Gaussian-smoothed at 5mm-full width half
maximum. Nuisance variables were also added to the design matrix: estimated movement
was added in the form of 12 additional regressors (3 translations, 3 rotations, 3
translations shifted 1 TR before and 3 translations shifted 1 TR later). Each individual
fMRI time series underwent automatic spike detection, using a mean-squared based
metric to identify unexpected values temporally and spatially slice per slice. Time-points
with artifacts (if any) of each sequence were regressed out of each participant’s data by
adding a corresponding number of regressors with value 1 at the time- point of the
artifact and 0 elsewhere to the design matrix.
Functional Tasks Descriptions
Stop Signal Task (SST). The SST required volunteers to respond to regularly presented
visual go stimuli (arrows pointing left or right) but to withhold their motor response when
the go stimulus was followed unpredictably by a stop-signal (an arrow pointing upwards).
Stopping difficulty was manipulated across trials by varying the delay between the onset
of the go arrow and the stop arrow (stop-signal delay, SSD) using a previously described
tracking algorithm (Rubia et al., 2005). A block contained 400 go trials and 80 variable
delay stop trials with between 3 and 7 go trials between two stop trials. Stimulus duration
in go trials was 1000 ms and in stop trials varied (0– 900ms in 50 ms steps) in accordance
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with the tracking algorithm (initial delay = 250 ms). We calculated contrast images for
successful inhibitions (“stop success”) and unsuccessful inhibitions (“stop fail”), both vs.
an implicit baseline.
Monetary Incentive Delay. The Monetary Incentive Delay (MID) task (adapted from a
task described previously (Knutson et al., 2001)) required participants to respond to a
briefly presented target by pressing either a left-hand or right-hand button as quickly as
possible to indicate whether the target appeared on the left or the right side of the monitor
display. If the participants responded while the target was on the screen, they scored
points but if they responded before the target appeared or after the offset of the target
they received no points. A cue preceded the onset of each trial, reliably indicating the
position of the target and the number of points awarded for a successful response. A
triangle indicated no points (No Win), a circle with one line 2 points (Small Win) and a
circle with three lines 10 points (Large Win). Twenty-two trials of each type were
presented in a pseudo-random order. The duration of the target was adjusted adaptively
so that 66% of the trials produced a correct response. The participants were informed that
at the end of the session they would receive one candy (M&M) for every five points won.
We calculated contrast images for the anticipation period of Large Win minus No Win,
and the outcome period for Large Win minus No Win.
Face Task. The Face task involved passive viewing of video clips that displayed
ambiguous (emotionally ‘‘neutral’’) or angry face expressions or control (nonbiological
motion) stimuli (Grosbras, 2005). Each trial consisted of short (2 to 5 s) black-and-white
video clips depicting either a face in movement or the control stimulus. The control
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stimuli consisted of black-and-white concentric circles of various contrasts, expanding
and contracting at various speeds, roughly matching the contrast and motion
characteristics of the face clips. The stimuli were presented through goggles (Nordic
ο
ο
Neurolabs, Bergen, Norway) in the scanner and subtended a visual angle of 10 by 7 .
The video clips were arranged into 18-s blocks; each block included seven to eight video
clips. Five blocks of each biological-motion condition (neutral and angry faces), and nine
blocks of the control condition (circles) were intermixed and presented to the participant
in a 6-minute run. We calculated contrast images from angry faces minus control stimuli,
neutral faces minus control stimuli, and angry faces minus neutral faces. After the
scanning session, participants completed a recognition task in which they were presented
with three of the faces previously presented in the scanning session and two novel faces.
Personality
NEO. Broad dimensions of personality were assessed using the 60-item NeuroticismExtraversion-Openness Five-Factor Inventory (NEO-FFI), which returns measures on the
dimensions of Extraversion, Agreeableness, Conscientiousness, Neuroticism, and
Openness to Experience as described in the Five-Factor Model of personality (Costa Jr. &
McCrae, 1995). The Extraversion factor assesses preference for seeking and engaging in
social interactions and may be linked to sensitivity to rewarding environmental cues
(Watson & Clark, 1992). The Agreeableness factor assesses empathy and an individual’s
tendency

towards

compassion

and

co-operation

rather

than

self-interest.

Conscientiousness provides a measure of the degree to which a participant exercises selfdiscipline and expresses a preference for planned, rather than spontaneous, behavior. The
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Neuroticism factor captures emotional liability and a tendency to experience lowered
mood and elevated anxiety. Openness to Experience measures intellectual curiosity and
creativity; lower scores on ‘openness’ are associated with a reduced tolerance for change
and a preference for familiarity over novelty.
Substance Use Risk Profile Scale. The Substance Use Risk Profile Scale (SURPS;
(Woicik et al., 2009)) assesses personality traits that confer risk for substance misuse and
psychopathology. This scale measures four distinct and independent personality
dimensions; anxiety sensitivity, hopelessness, sensation seeking, and impulsivity. The
anxiety sensitivity dimension is characterized by the fear of symptoms of physical
arousal. The hopelessness dimension is identified as a risk factor for the development of
depression and characterized by dismal feelings. The sensation seeking dimension is
characterized by the desire for intense and novel experiences. The impulsivity dimension
involves difficulties in the regulation (controlling) of behavioral responses.
Temperament and Character Inventory. The novelty seeking scale of the
Temperament and Character Inventory – Revised (TCI-R; (Cloninger, 1999)) was
administered. The novelty seeking scale is composed of four subscales (excitability,
impulsiveness, extravagance, and disorderliness). The excitability subscale contrasts with
‘stoic rigidity’ and reflects sensation-seeking and novelty-seeking behaviors. The
impulsiveness subscale describes behavior on a dimension from impulsivity to reflection
and captures elements of emotional reactivity, and unreflective, careless behavior. The
extravagance subscale assesses overspending behavior and poor planning and is believed
to reflect a tendency to approach reward cues. The disorderliness subscale reflects
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disorganized, uncontrolled, and anti-normative behavior. Novelty seeking personality is
assessed as the sum across all four subscales.
Cognition
Wechsler Intelligence Scale for Children. Participants completed a version of the
Wechsler Intelligence Scale for Children WISC-IV(Wechsler, 2003), of which we
included the following subscales. Perceptual Reasoning, consisting of Block Design
(arranging bi-colored blocks to duplicate a printed image) and Matrix Reasoning (in
which a series of colored matrices are presented and the child is asked to select the
consistent pattern from a range of options). Verbal Comprehension consisting of
Similarities (two similar but different objects or concepts are presented and the child is
asked to explain how they are alike or different) and Vocabulary (a picture is presented or
a word is spoken aloud by the experimenter and the child is asked to provide the name of
the depicted object or to define the word).
Delay discounting. The Monetary-Choice Questionnaire (MCQ; (Kirby, Petry, & Bickel,
1999)) was administered to provide a measure of preference for immediate lower over
delayed higher monetary rewards. The MCQ is a 27-item task in which the participant
chooses between a smaller, immediate monetary reward and a larger, delayed monetary
reward (e.g. €25 today or €60 in 14 days), with varying discrepancies and delays between
the rewards. The task indexes impulsivity by providing a measure of the degree to which
future rewards are diminished or discounted. The protocol is scored by calculating where
the participant’s answers place them in comparison to reference discounting curves,
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where placement amid steeper curves indicates higher levels of impulsivity.
CANTAB. Participants completed five of the CANTAB tests.
The Affective Go/No-go task comprised of alternating blocks in which participants were
presented with positively or negatively valenced target words embedded in a stream of
neutral distracter words. Participants were instructed to respond to targets with a button
press. Measures included in the analyses were the total number of omissions to positive
and negative targets, and the average response latency to positive and negative target
words.
In the Pattern Recognition Memory task participants were required to remember 12
abstract patterns; the percentage of patterns correctly recognized on a two alternative
forced choice task completed immediately after encoding was included in the analyses.
The Spatial Working Memory Task required participants to “search” for a token hidden
by one of a number of boxes on the monitor by selecting the boxes in sequence. Once the
token is uncovered, participants must search again with the condition that the token will
not be hidden in the same location more than once. The number of times participants
returned to search a box that had already contained the token was entered into the
analyses as an error measure. We also included a strategy score (ranging from 1-37, with
lower scores indicating a more strategic approach), which reflects how often a search
sequence was initiated from a novel position.
The Rapid Visual Information Processing task comprised of a stream of digits presented
at 1.67Hz and participants were required to monitor the stream for target sequence of
three digits. We included a signal detection measure of sensitivity to the target sequence
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in the analyses.
The Cambridge Guessing Task (CGT) was a modified version of the Cambridge
Gambling Task, renamed in order to make it appropriate to administer to adolescents. On
each trial of the CGT the participant was presented with 10 boxes, some of which are
blue, some of which are red, and must “guess” which color box conceals a hidden yellow
token. Participants start the task with 100 points and lose or acquire points by wagering
on their guess. The options the participant can choose to wager are determined by the
program as a proportion of their total number of points, presented in either increasing or
decreasing amounts. The analyses included measures of the time taken to select the
option on which to bet, an average of the proportion of the total number of points
wagered on each trial, the proportion of trials on which the more likely outcome was
selected (quality of decision making), an average of the proportion wagered on trials
when the participant selected the more likely result (rational bets), and an index of delay
aversion reflected in making higher bets when the amount to bet is presented in
descending order rather than in ascending order.
Behavioral data from functional imaging tasks. Behavioral data from the Monetary
Incentive Delay (reward) task were as follows: the number of Big Win trials on which the
target was not hit, the number of Big Win trials on which the target was hit, the number
of Small Win trials on which the target was not hit, the number of Small Win trials on
which the target was hit, the number of No Win trials on which the target was not hit, and
the number of No Win trials on which the target was hit. Behavioral data from the Faces
(emotional reactivity) task included the number of targets and the number of foils
correctly categorized. Participants were not informed prior to the scanning session about
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the subsequent recall task. Behavioral data from the stop signal task was incomplete due
to technical errors, therefore this data was omitted from the modeling procedures,
however, the stop signal task had an adaptive performance algorithm to account for
individual differences in reaction time.
History
Life-Events Questionnaire. The Life-Events Questionnaire (LEQ) is an adaptation of
the Stressful Life-Event Questionnaire (Newcomb et al., 1981), which uses 39 items to
measure the lifetime occurrence (frequency) and the perceived desirability of stressful
events covering the following domains: Family/Parents, Accident/Illness, Sexuality,
Autonomy, Deviance, Relocation, and Distress. The life-events valence labels measured
on an ordinal scale from -2 to +2 as follows: -2='Very Unhappy', -1='Unhappy',
0='Neutral', +1='Happy', +2='Very Happy'.
Gestational cigarette and alcohol exposure. The Pregnancy and Birth Questionnaire
(PBQ, adapted from (Pausova et al., 2007)) assesses exposure of the child to potentially
harmful conditions and substances such as maternal alcohol, cigarette, and cannabis use
before and during pregnancy. The questionnaire was completed by each participant’s
parent or guardian and parental cigarette and alcohol use during pregnancy were
recorded, then recoded as binary variables.
Alcohol Misuse. Michigan Alcohol Screening Test questions (MAST; (Selzer, 1971) ),
such as ‘have you ever been in a hospital because of drinking’, was used to assess alcohol
misuse. Parental alcohol misuse was assessed using the Parent-Alcohol Use Disorders
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Identification Test (AUDIT; (Saunders et al., 1993)).
Puberty Development Scale. The Puberty Development Scale (PDS; (Petersen et al.,
1988)) was used to assess the pubertal status of each participant. This scale provides an
eight-item self-report measure of physical development based on the Tanner stages with
separate forms for males and females. For this scale, there are five categories of pubertal
status: 1=prepubertal, 2=beginning pubertal, 3=midpubertal, 4=advanced pubertal,
5=postpubertal. Participants answered questions about their growth in stature and pubic
hair, as well as menarche in females and voice changes in males.
Socioeconomic Status. The socioeconomic status score was comprised of the sum of the
following variables: Mother’s Education Score, Father’s Education Score, Family Stress
Unemployment Score, Financial Difficulties Score, Home Inadequacy Score,
Neighborhood Score, Financial Crisis Score, Mother Employed Score, Father Employed
Score.
Substance misuse measures. The European School Survey Project on Alcohol and
Drugs (ESPAD; (Hibell et al., 1997)) was administered using the software program
Psytools (London, UK) which is a computerized assessment platform. Psytools presented
questionnaire items and response alternatives on a computer screen. Jump rules were
implemented where applicable to skip irrelevant questions (e.g., drinking-related
questions in self-reported non-drinkers) for the sake of brevity. As the Psytools program
was run at the participant’s home without direct supervision by the research team, the
reliability of the data were checked in a two-stage procedure. Before every task,
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adolescents were asked to report on the current testing context including questions about
their attentional focus and the confidentiality of the setting. Automated flags highlighted
potentially problematic testing situations and were followed-up by research assistants
face-to-face with the volunteer in a confidential setting. Final reliability ratings were
assigned which led to exclusion of the data. Exclusion criteria for substance use measures
included an indication that the participant was in a hurry, somebody was watching, or an
indication to have known or taken the sham drug Relevin. Inconsistency between
baseline (age 14 years) and follow up (age 16 years) for all drugs was also an exclusion
criterion (e.g., scoring 1 for cannabis at age 14 years, but 0 at age 16 years). Drug-usage
levels were collected on an ordinal scale, 0=0, 1=1-2x, 2=3-5x, 3=6-9x, 4=10-19x, 5=2039x, 6=40x+.
Genotyping
DNA purification and genotyping was performed by the Centre National de Génotypage
in Paris. DNA was extracted from whole blood samples preserved in ethylene-eiaminetetra-acetic acid vacutainer tubes (BD, Becton, Dickinson and Company, Oxford, United
Kingdom) using Gentra Puregene Blood Kit (QIAGEN, Valencia, California) according
to the manufacturer’s instructions. Genotype information was collected at 582,892
markers using the Illumina HumanHap610 and HumanHap660 Genotyping BeadChips
(San Diego, California). The SNPs with call rates of <95%, minor allele frequency < 1%,
deviation from the Hardy-Weinberg equilibrium (“HWE”, p ≤ 1 × 10-6), and nonautosomal SNPs were excluded.
Markers data imputation and quality control for ambiguous SNPs, low MAF, missingness
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and HWE were done with MACH (Li et al., 2010), following the ENIGMA2 guidelines.
The 1000 Genomes project reference set of markers (http://www.1000genomes.org/data)
was used for the imputation after decreasing the markers from ~41 million to ~13 million
relevant genetic variants observed more than once in the European populations
Genetic Analysis Four multidimensional scaling (MDS) components were calculated
using a metric model in PLINK v1.9 (http://pngu.mgh.harvard.edu/~purcell/plink/). MDS
was then included as a covariate to account for population stratification as part of the
cross-validation logistic regression, where the genotypes were coded following an
additive model (as 0, 1, and 2 for the number of risk alleles).
Imputation of Missing Data
Missing data for all three domains were replaced (where possible) by imputation.
Continuous variables were replaced with the 95% trimmed mean derived according to the
participant’s site and sex taken from the whole IMAGEN database (N=2,462). Ordinal
data were similarly replaced with the mode of that variable for the participant’s site and
sex.
Analytic Methods
Use of a cross-validation scheme allows for the tuning of the elastic-net regularization
parameters for optimal feature selection and provides an assessment of model overfitting.
The area under the curve (AUC) of the receiver-operating characteristic (ROC) was
calculated for each run based on the model’s ability to predict age 16 cannabis use in the
set-aside test-folds, thereby quantifying the test error of the final predictive model.
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Elastic Net regularization and feature selection. Regression with Elastic Net
regularization is an example of a sparse regression method, which imposes a hybrid of
both L1- and L2-norm penalties (i.e., penalties on the absolute (L1-norm) and squared
values of the β weights (L2-norm)). This allows relevant but correlated coefficients to
coexist in a sparse model fit, by doing automatic variable selection and continuous
shrinkage simultaneously, and selects or rejects groups of correlated variables. Least
absolute shrinkage and selection operator (LASSO; (Tibshirani, 1996)) and ridge
regression are special separate cases of regularized regression. All independent variables
were standardized prior to model estimation. These analyses were implemented using the
“glmnet” function in MATLAB (Natick, MA).
The analysis was executed 100 times to incorporate the subtle differences in results
incurred due to the random assignment of participants to folds. As a 10-fold cross
validation scheme was implemented 100 times per analysis, results were thresholded to
identify only the predictors present in a minimum 6 out of 10 final-models (from k=10),
across a minimum of 80 runs.
To investigate sex differences, analyses were conducted on a male-only sample (N=648;
age 16 cannabis-users n=110) and a female-only sample (N=741; age 16 cannabis-users
n=63). For each sex, the analysis returned a reduced design matrix of significant
predictors [p x 10 (βs-per-fold)] x 100 runs. Null-hypothesis significance testing on the
AUC was conducted using a Mann-Whitney U-test (Mason & Graham, 2002).

Gene-only Analysis
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Given our interest in uncovering potential genetic predictors of adolescent cannabis use, a
gene-specific analysis was conducted by collapsing across sex and included only genetic
data and covariates (age, sex, handedness, puberty status, and four MDS scores) as
independent variables. A less conservative threshold was applied to identify SNP
predictors. As such, SNPs selected in four or more final models across a minimum of 50
runs was used. Despite this lenient threshold, post-hoc hierarchical regression analyses
confirmed that including these 3 SNPs returned strong model fit statistics relative to a
model estimated using only the eight nuisance covariates (see main text).
Head Motion
As head motion has been shown to confound structural and functional MRI findings
(Pardoe, Kucharsky Hiess, & Kuzniecky, 2016), a-priori 2-sample t-tests confirmed that
head motion (mean framewise displacement, “FD”) within each task did not differ
between age 16 users and controls for either sex. The framewise displacement (FD) for
each participant for each fMRI task was calculated using the six displacement parameters
estimated during image realignment preprocessing procedures (see table A1.2 for
statistics).
Permutation Analyses
To check for spurious findings and to confirm the independence of the 10-fold model
training and testing procedure, random permutation analyses were conducted. Each sexspecific k-fold analysis was repeated 100 times while randomly assigning group
membership to each participant while keeping original group sample sizes consistent.
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Essentially, these analyses tested for significant findings on a sample-generated null
model. These permutation models performed no better than chance (Males: mean AUC =
0.53, σ =.02, p > .05; Females: mean AUC= 0.51, σ =.03, p > .05). In addition to these
models failing to predict randomized outcomes, the predictors selected for each final
model did not mirror the predictors selected from the true analyses.

Post-hoc Multiple Regression Modeling
The predictors of cannabis use identified from the preceding sex-specific k-fold analyses
were selected for use as the independent variables in a multiple logistic regression model
assessing sex- and drug-specificity. Sex-specificity was assessed by including the
predictors of male cannabis use in a multiple logistic regression model estimated on the
entire female sample (and vice versa). Drug-specificity was assessed in a similar fashion
while using a related but independent sample of binge drinking adolescents. In all posthoc scenarios, independent variables were standardized to z-scores by sex before model
estimation. Thereafter, coefficients and model fit statistics were freely estimated from
their respective samples. The “model with predictors” consisted of a multiple-regression
model containing the predictors identified from the respective preceding sex-specific kfold analyses. Each model with predictors was compared to its sample-specific base rate
model, which corresponds to a threshold at which the exact baseline rate would be
classified as a cannabis user or binge drinker by age 16.
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